Manning & Napier Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Buy
184,742
+1,587
+0.9% +$91.1K 0.14% 95
2026
Q1
$11.1M Sell
183,155
-5,851
-3% -$341K 0.16% 93
2025
Q4
$10.2M Sell
189,006
-22,048
-10% -$1.06M 0.13% 94
2025
Q3
$9.52M Sell
211,054
-182,839
-46% -$8.54M 0.12% 93
2025
Q2
$18.2M Sell
393,893
-81,187
-17% -$3.99M 0.22% 77
2025
Q1
$29M Sell
475,080
-34,284
-7% -$2M 0.36% 64
2024
Q4
$28.8M Sell
509,364
-48,363
-9% -$2.7M 0.33% 66
2024
Q3
$28.9M Sell
557,727
-8,249
-1% -$387K 0.32% 66
2024
Q2
$23.5M Buy
+565,976
New +$25.3M 0.27% 76
2017
Q3
$120M Sell
1,884,716
-149,886
-7% -$8.75M 1.03% 38
2017
Q2
$113M Sell
2,034,602
-1,201,976
-37% -$65.4M 0.97% 35
2017
Q1
$176M Buy
3,236,578
+176,298
+6% +$9.67M 1.36% 27
2016
Q4
$179M Buy
+3,060,280
New +$167M 1.17% 34
2014
Q2
Sell
-206,869
Closed -$10.7M 368
2014
Q1
$10.7M Sell
206,869
-35,092
-15% -$1.87M 0.04% 166
2013
Q4
$12.9M Sell
241,961
-24,494
-9% -$1.25M 0.06% 133
2013
Q3
$12.3M Buy
266,455
+1,725
+0.7% +$75.7K 0.06% 139
2013
Q2
$11.8M Buy
+264,730
New +$11.5M 0.06% 144

Other funds holding BMY

Manning & Napier Advisors's BMY Position: Q2 2026 in Review

Manning & Napier Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.87% in Q2 2026, buying an estimated $91.1K and bringing the position to 184,742 shares worth $10.8M. The position accounts for 0.14% of the portfolio, ranked #95.

Manning & Napier Advisors first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $179M in Q4 2016. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Manning & Napier Advisors held 184,742 shares of Bristol-Myers Squibb worth $10.8M as of Q2 2026.
  • Manning & Napier Advisors bought 1,587 Bristol-Myers Squibb shares in Q2 2026, an estimated $91.1K.
  • Bristol-Myers Squibb made up 0.14% of Manning & Napier Advisors's portfolio in Q2 2026, its #95 holding.
  • Manning & Napier Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
  • Manning & Napier Advisors's Bristol-Myers Squibb position peaked at $179M in Q4 2016.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.